Henderson Jane

Lycia Therapeutics, Inc. reports stock options

Jane Henderson, insider filing for LYCA

Form
4
Filed
Importance
Routine
  1. Stock options granted on Aug 11, 2026 for 57,666 shares
  2. Stock options granted on Oct 22, 2026 for 20,000 shares
  3. Options vest over four years with first tranche on Aug 6, 2026

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Get an email when Henderson Jane files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.